Free Trial
LON:APH

Alliance Pharma (APH) Share Price, News & Analysis

Alliance Pharma logo

About Alliance Pharma Stock (LON:APH)

Key Stats

Today's Range
N/A
50-Day Range
64.70
▼
64.70
52-Week Range
N/A
Volume
N/A
Average Volume
5.95 million shs
Market Capitalization
£350.32 million
P/E Ratio
N/A
Dividend Yield
3.75%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APH Stock News Headlines

RBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Alliance Pharma Regulatory News
See More Headlines

APH Stock Analysis - Frequently Asked Questions

Alliance Pharma plc (LON:APH) posted its quarterly earnings data on Tuesday, April, 8th. The company reported $4.32 earnings per share (EPS) for the quarter. Alliance Pharma had a negative net margin of 6.00% and a negative trailing twelve-month return on equity of 5.04%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include Aviva (AV), BAE Systems (BA), Babcock International Group (BAB), boohoo group (BOO), BP (BP), Centrica (CNA) and The Gym Group (GYM).

Company Calendar

Last Earnings
4/08/2025
Today
10/14/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
LON:APH
CIK
N/A
Fax
N/A
Employees
91,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (6.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
12.47
P/E Growth
1.04
Net Income
-£33.65 million
Net Margins
-6.00%
Pretax Margin
N/A
Return on Equity
-5.04%
Return on Assets
5.98%

Debt

Debt-to-Equity Ratio
46.09
Current Ratio
2.84
Quick Ratio
1.42

Sales & Book Value

Annual Sales
£183.50 million
Price / Sales
1.91
Cash Flow
GBX 8.22 per share
Price / Cash Flow
7.87
Book Value
GBX 41.25 per share
Price / Book
1.57

Miscellaneous

Outstanding Shares
541,444,969
Free Float
N/A
Market Cap
£350.31 million
Optionable
Not Optionable
Beta
0.67
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (LON:APH) was last updated on 5/14/2025 by MarketBeat.com Staff.
From Our Partners